6-Amino-4-hydroxyamino-2-(β-D-ribofuranosyl)-2H-pyrazolo[3,4-d]pyrimidine
CAT:
804-HY-152414
Size:
Inquire
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No
![6-Amino-4-hydroxyamino-2-(β-D-ribofuranosyl)-2H-pyrazolo[3,4-d]pyrimidine - image 1](/gentaur-product-1.webp)
![6-Amino-4-hydroxyamino-2-(β-D-ribofuranosyl)-2H-pyrazolo[3,4-d]pyrimidine - image 1](/gentaur-product-1.webp)
6-Amino-4-hydroxyamino-2-(β-D-ribofuranosyl)-2H-pyrazolo[3,4-d]pyrimidine
UNSPSC Description:
6-Amino-4-hydroxyamino-2-(β-D-ribofuranosyl)-2H-pyrazolo[3,4-d]pyrimidine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].Target Antigen:
Nucleoside Antimetabolite/AnalogType:
OligonucleotidesRelated Pathways:
Cell Cycle/DNA DamageApplications:
Cancer-programmed cell deathField of Research:
OthersAssay Protocol:
https://www.medchemexpress.com/6-amino-4-hydroxyamino-2-β-d-ribofuranosyl-2h-pyrazolo-3-4-d-pyrimidine.htmlSolubility:
10 mM in DMSOSmiles:
O[C@H]1[C@@H](O)[C@H](N2N=CC3=C2N=C(N)N=C3NO)O[C@@H]1COMolecular Weight:
298.26References & Citations:
[1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.Shipping Conditions:
Room temperatureClinical Information:
No Development Reported